FindTrial
Sign In

The study on the application of vNOTES treatment of benign gynecologic disease in the era of COVID-19

The study on the application of vNOTES treatment of benign gynecologic in the era of COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064125
Enrollment
Unknown
Registered
2022-09-27
Start date
2022-09-27
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign gynecologic disease

Interventions

two:vNOTES group

Sponsors

The affiliated Nanchong Central Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Preoperative ultrasound, CT, MRI or contrast-enhanced examination (uterine lipiodol contrast, contrast-enhanced ultrasound) considered gynecological benign diseases and indicated for surgery; 2. Patients diagnosed as gynecological benign diseases with no contraindications for surgical treatment and tolerant to surgery; 3. Patients with preoperative sexual history; 4. Aware of this study, willing to accept various questionnaires and scales investigation and evaluation, accept postoperative follow-up; 5. Patients without physical disease or mental disease or history of psychoactive substance use.

Exclusion criteria

Exclusion criteria: 1. Patients who can not exclude malignant tumors or combined with other malignant tumors; 2. Patients without sexual history before surgery; 3. The test plan is not used, or the record of the test plan is incomplete.

Design outcomes

Primary

MeasureTime frame
Return to work time;—

Countries

China

Contacts

Public ContactYing Tang

The affiliated Nanchong Central Hospital of North Sichuan Medical College

925393235@qq.com19960846866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026